文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血后持续输注低剂量普通肝素:认知结局的初步研究

Continuous infusion of low-dose unfractionated heparin after aneurysmal subarachnoid hemorrhage: a preliminary study of cognitive outcomes.
PubMed 文献 · J Neurosurg · 2018-05-11

该回顾性分析纳入2009年7月至2014年4月治疗的动脉瘤性蛛网膜下腔出血(aSAH)患者,比较马里兰低剂量静脉肝素(LDIVH)方案组与对照组的蒙特利尔认知评估(MoCA)评分。LDIVH组平均MoCA为26.4,对照组为22.7(p=0.013);严重认知障碍(MoCA≤20)在对照组为32%,LDIVH组为0%(p=0.008);线性回归显示仅LDIVH与MoCA评分正相关(β=3.68,p=0.019)。作者认为该初步研究提示马里兰LDIVH方案可能改善aSAH患者认知结局,需随机对照试验确定普通肝素的安全性和潜在获益。

要点

  • LDIVH组平均MoCA 26.4 vs 对照组22.7(p=0.013)。
  • 严重认知障碍(MoCA≤20)对照组32% vs LDIVH组0%(p=0.008)。
  • 仅LDIVH与MoCA评分正相关(β=3.68,p=0.019),无治疗并发症。

核心结论

  • 该初步研究提示马里兰LDIVH方案可能改善aSAH患者认知结局,需随机对照试验确定普通肝素的安全性和潜在获益。

研究设计与样本

  • 回顾性分析2009年7月至2014年4月治疗的所有aSAH患者,自2012年起aSAH患者在术后接受LDIVH治疗。
  • 由对治疗状态设盲的培训人员,在aSAH后至少3个月的常规随访中前瞻性对所有aSAH存活者实施MoCA。
  • 比较组间平均MoCA评分,并对相关因素进行回归分析。

主要发现

  • 组间基线特征无显著差异。
  • LDIVH组(n=25)平均MoCA评分为26.4,对照组(n=22)为22.7(p=0.013)。
  • 严重认知障碍(MoCA≤20)在对照组为32%,在LDIVH组为0%(p=0.008)。
  • 线性回归分析显示仅LDIVH与MoCA评分正相关(β=3.68,p=0.019),前交通动脉动脉瘤和发热与MoCA评分负相关。
  • 多变量线性回归分析显示所有3个因素均保持显著性,无治疗并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文标题和结论写明为初步研究(preliminary study)。
  • 原文结论指出需随机对照试验确定普通肝素在aSAH患者中的安全性和潜在获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cognitive dysfunction occurs in up to 70% of aneurysmal subarachnoid hemorrhage (aSAH) survivors. Low-dose intravenous heparin (LDIVH) infusion using the Maryland protocol was recently shown to reduce clinical vasospasm and vasospasm-related infarction. In this study, the Montreal Cognitive Assessment (MoCA) was used to evaluate cognitive changes in aSAH patients treated with the Maryland LDIVH protocol compared with controls. METHODS: A retrospective analysis of all patients treated for aSAH between July 2009 and April 2014 was conducted. Beginning in 2012, aSAH patients were treated with LDIVH in the postprocedural period. The MoCA was administered to all aSAH survivors prospectively during routine follow-up visits, at least 3 months after aSAH, by trained staff blinded to treatment status. Mean MoCA scores were compared between groups, and regression analyses were performed for relevant factors. RESULTS: No significant differences in baseline characteristics were observed between groups. The mean MoCA score for the LDIVH group (n = 25) was 26.4 compared with 22.7 in controls (n = 22) (p = 0.013). Serious cognitive impairment (MoCA ≤ 20) was observed in 32% of controls compared with 0% in the LDIVH group (p = 0.008). Linear regression analysis demonstrated that only LDIVH was associated with a positive influence on MoCA scores (β = 3.68, p =0.019), whereas anterior communicating artery aneurysms and fevers were negatively associated with MoCA scores. Multivariable linear regression analysis resulted in all 3 factors maintaining significance. There were no treatment complications. CONCLUSIONS: This preliminary study suggests that the Maryland LDIVH protocol may improve cognitive outcomes in aSAH patients. A randomized controlled trial is needed to determine the safety and potential benefit of unfractionated heparin in aSAH patients.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. James RF, Khattar NK, Aljuboori ZS, et al. Continuous infusion of low-dose unfractionated heparin after aneurysmal subarachnoid hemorrhage: a preliminary study of cognitive outcomes. J Neurosurg. 2018. PMID: 29749915. doi:10.3171/2017.11.JNS17894

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。